Search Results (1 to 10 of 4611 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 1323 Journal of Medical Internet Research
- 838 JMIR Research Protocols
- 577 JMIR Formative Research
- 358 JMIR mHealth and uHealth
- 185 JMIR Mental Health
- 181 JMIR Public Health and Surveillance
- 144 JMIR Medical Informatics
- 135 JMIR Human Factors
- 131 Online Journal of Public Health Informatics
- 87 JMIR Cancer
- 68 JMIR Aging
- 68 JMIR Serious Games
- 63 JMIR Pediatrics and Parenting
- 57 JMIR Medical Education
- 54 Iproceedings
- 52 Interactive Journal of Medical Research
- 41 JMIR Diabetes
- 39 JMIR Cardio
- 35 JMIR Rehabilitation and Assistive Technologies
- 33 JMIR Dermatology
- 22 JMIR AI
- 22 JMIR Nursing
- 22 JMIRx Med
- 21 JMIR Perioperative Medicine
- 21 Journal of Participatory Medicine
- 18 JMIR Infodemiology
- 6 JMIR Bioinformatics and Biotechnology
- 4 JMIR Neurotechnology
- 3 JMIR Biomedical Engineering
- 1 Asian/Pacific Island Nursing Journal
- 1 JMIR XR and Spatial Computing (JMXR)
- 1 Medicine 2.0
- 0 iProceedings
- 0 JMIR Preprints
- 0 JMIR Challenges
- 0 JMIR Data
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section

M-Cubed, an adaptation of Health Mindr that provides pop-up HIV prevention messaging, demonstrated efficacy to increase HIV testing and Pr EP uptake among urban MSM [17].
There is a need to understand which components of app-based HIV prevention are necessary to promote prevention to inform future implementation. A standard feature of most app-based HIV prevention interventions is access to free HIV and STI self-test kits [30-32].
JMIR Res Protoc 2025;14:e69540
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section

Several risk factors for the development of ILD in patients with RA have been identified, including older age, male sex, cigarette smoking, and the presence of positive anticyclic citrullinated peptide antibodies or immunoglobulin M rheumatoid factor [6-9].
RA-ILD can be classified into acute, subacute, and chronic forms based on the clinical presentation. In patients with acute RA-ILD, characterized by diffuse alveolar damage, high-dose corticosteroids are typically the first-line treatment.
JMIR Res Protoc 2025;14:e73219
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section
Go back to the top of the page Skip and go to footer section